Experts Seek To Develop Breast Cancer Screening, Treatment In Developing Countries
international task force of cancer specialists and charities is meeting this week to develop
strategies for curbing rising breast cancer rates in developing countries, the AP/Washington Post
reports. The task force is led by Felicia Knaul — a public health specialist and director of Harvard
University’s Global Equity Initiative — and Lawrence Shulman of the Dana Farber Cancer Institute.
Almost two-thirds of women in developing countries are not diagnosed with the disease until it
has spread, the AP/Post reports. Compounding the problem are new data from Harvard that
show women in developing countries appear to develop breast cancer, on average, about 10
years earlier than women in the U.S.
The team plans to launch cancer care programs in parts of Africa. In a two-part approach, the
task force aims to first educate midwives and other rural health care providers on how to conduct
routine manual breast exams, particularly where mammography machines are unattainable. The
specialists acknowledged that the method might not detect the smallest tumors, but it could
significantly improve diagnosis in some areas. For the second part of the plan, the task force will
attempt to reach agreements with drugmakers to provide lower-cost generic chemotherapy in
developing countries — the same model used to advance HIV/AIDS care in parts of Africa.
The true number of breast cancer cases in developing countries is unknown because of poor
diagnosis and insufficient record-keeping. However, the Harvard report estimated that 55% of the
450,000 expected breast cancer deaths worldwide this year will be in developing countries. The
breast cancer rate in the poorest countries will rise by 36% by 2020, the report estimates
(Neergaard, AP/Washington Post, 11/3).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the
entire Daily Women’s Health Policy Report, search the archives, or sign up for e